These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 2872654)
1. Facilitation, augmentation and potentiation of transmitter release at frog neuromuscular junctions poisoned with botulinum toxin. Lupa MT; Tabti N Pflugers Arch; 1986 Jun; 406(6):636-40. PubMed ID: 2872654 [TBL] [Abstract][Full Text] [Related]
2. Studies on the mode of action of botulinum toxin type A at the frog neuromuscular junction. Molgó J; Thesleff S Brain Res; 1984 Apr; 297(2):309-16. PubMed ID: 6326941 [TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin and 4-aminoquinoline induce a similar abnormal type of spontaneous quantal transmitter release at the rat neuromuscular junction. Thesleff S; Molgó J; Lundh H Brain Res; 1983 Mar; 264(1):89-97. PubMed ID: 6133583 [TBL] [Abstract][Full Text] [Related]
4. Ultrastructure of botulinum type-A poisoned frog motor nerve terminals after enhanced quantal transmitter release caused by carbonyl cyanide m-chlorophenylhydrazone. Pécot-Dechavassine M; Molgo J; Thesleff S Neurosci Lett; 1991 Sep; 130(1):5-8. PubMed ID: 1684235 [TBL] [Abstract][Full Text] [Related]
5. A study of synchronization of quantal transmitter release from mammalian motor endings by the use of botulinal toxins type A and D. Molgó J; Siegel LS; Tabti N; Thesleff S J Physiol; 1989 Apr; 411():195-205. PubMed ID: 2575665 [TBL] [Abstract][Full Text] [Related]
6. Miniature end-plate potentials in rat skeletal muscle poisoned with botulinum toxin. Kim YI; Lømo T; Lupa MT; Thesleff S J Physiol; 1984 Nov; 356():587-99. PubMed ID: 6520797 [TBL] [Abstract][Full Text] [Related]
7. A comparison of miniature end-plate potentials at normal, denervated, and long-term botulinum toxin type A poisoned frog neuromuscular junctions. Lupa MT; Yu SP Pflugers Arch; 1986 Nov; 407(5):476-81. PubMed ID: 3024099 [TBL] [Abstract][Full Text] [Related]
8. Aminoglycosides and 3,4-diaminopyridine on neuromuscular block caused by botulinum type A toxin. Molgó J; Lemeignan M; Thesleff S Muscle Nerve; 1987 Jun; 10(5):464-70. PubMed ID: 3497343 [TBL] [Abstract][Full Text] [Related]
9. In botulinum type A-poisoned frog motor endings ouabain induces phasic transmitter release through Na+-Ca2+ exchange. Molgo J; Angaut-Petit D; Thesleff S Brain Res; 1987 May; 410(2):385-9. PubMed ID: 3036311 [TBL] [Abstract][Full Text] [Related]
10. Effects of botulinum toxin on neuromuscular transmission in the rat. Cull-Candy SG; Lundh H; Thesleff S J Physiol; 1976 Aug; 260(1):177-203. PubMed ID: 184273 [TBL] [Abstract][Full Text] [Related]
11. Pre- and post-synaptic actions of botulinum toxin at the rat neuromuscular junction. Sellin LC; Thesleff S J Physiol; 1981 Aug; 317():487-95. PubMed ID: 6273549 [TBL] [Abstract][Full Text] [Related]
12. Effects of Mg2+ on the stimulation-induced changes in transmitter release at the frog neuromuscular junction. Tanabe N; Morota A; Kijima H Zoolog Sci; 1995 Jun; 12(3):265-70. PubMed ID: 7580810 [TBL] [Abstract][Full Text] [Related]
13. Modulation of Ca(2+)-dependent and Ca(2+)-independent miniature endplate potentials by phorbol ester and adenosine in frog. Searl TJ; Silinsky EM Br J Pharmacol; 2005 Aug; 145(7):954-62. PubMed ID: 15880138 [TBL] [Abstract][Full Text] [Related]
14. Transmitter release in tetanus and botulinum A toxin-poisoned mammalian motor endplates and its dependence on nerve stimulation and temperature. Dreyer F; Schmitt A Pflugers Arch; 1983 Nov; 399(3):228-34. PubMed ID: 6140670 [TBL] [Abstract][Full Text] [Related]
15. The reduction of endplate responses by botulinum toxin. Gundersen CB; Katz B; Miledi R Proc R Soc Lond B Biol Sci; 1981 Nov; 213(1193):489-93. PubMed ID: 6119693 [TBL] [Abstract][Full Text] [Related]
16. Different effects of botulinum A toxin and tetanus toxin on the transmitter releasing process at the mammalian neuromuscular junction. Dreyer F; Schmitt A Neurosci Lett; 1981 Nov; 26(3):307-11. PubMed ID: 6119657 [TBL] [Abstract][Full Text] [Related]
17. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction. Molgó J; del Pozo E; Baños JE; Angaut-Petit D Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201 [TBL] [Abstract][Full Text] [Related]
18. Actions of beta-bungarotoxin on spontaneous release of transmitter at muscle end-plates treated with botulinum toxin. Tse CK; Wray D; Melling J; Dolly JO Toxicon; 1986; 24(2):123-30. PubMed ID: 2871643 [TBL] [Abstract][Full Text] [Related]
19. Effects of aldrin-transdiol on neuromuscular facilitation and depression. Akkermans LM; van den Bercken J; van der Zalm J Eur J Pharmacol; 1975 Apr; 31(2):166-75. PubMed ID: 238851 [TBL] [Abstract][Full Text] [Related]
20. Ca(2+)-dependent and -independent components of transmitter release at the frog neuromuscular junction. Tanabe N; Kijima H J Physiol; 1992 Sep; 455():271-89. PubMed ID: 1484356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]